VKH
NAVB

Virtu KCG Holdings’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Virtu KCG Holdings’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$172K Buy
16,821
+12,674
+306% +$125K ﹤0.01% 2230
2017
Q1 		$48K Buy
4,147
+3,393
+450% +$38.5K ﹤0.01% 2853
2016
Q4 		$10K Buy
+754
New +$12K ﹤0.01% 3291
2016
Q3 		– Sell
-4,442
Closed -$47K – 3672
2016
Q2 		$47K Buy
+4,442
New +$87.3K ﹤0.01% 2690
2016
Q1 		– Sell
-5,204
Closed -$138K – 4001
2015
Q4 		$138K Buy
+5,204
New +$181K ﹤0.01% 2896
2015
Q3 		– Sell
-2,810
Closed -$90K – 4043
2015
Q2 		$90K Buy
2,810
+698
+33% +$20.3K ﹤0.01% 2939
2015
Q1 		$67K Buy
2,112
+1,525
+260% +$51.6K ﹤0.01% 2751
2014
Q4 		$22K Buy
+587
New +$16.1K ﹤0.01% 3592
2014
Q3 		– Sell
-3,508
Closed -$104K – 4294
2014
Q2 		$104K Buy
3,508
+1,361
+63% +$44K ﹤0.01% 3287
2014
Q1 		$80K Buy
2,147
+697
+48% +$26.4K ﹤0.01% 3259
2013
Q4 		$60K Sell
1,450
-948
-40% -$37.1K ﹤0.01% 3567
2013
Q3 		$127K Buy
+2,398
New +$140K ﹤0.01% 3305

Other funds holding NAVB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu KCG Holdings's NAVB Position: Q2 2017 in Review

Virtu KCG Holdings increased its Navidea Biopharmaceuticals Inc. (NAVB) stake by 306% in Q2 2017, buying an estimated $125K and bringing the position to 16,821 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #2230.

Virtu KCG Holdings first reported a position in NAVB in Q3 2013 and has held it in 12 quarters since. 52 funds tracked by Wall St. Rank hold NAVB as of Q2 2017.

  • Virtu KCG Holdings held 16,821 shares of Navidea Biopharmaceuticals Inc. worth $172K as of Q2 2017.
  • Virtu KCG Holdings bought 12,674 Navidea Biopharmaceuticals Inc. shares in Q2 2017, an estimated $125K.
  • Navidea Biopharmaceuticals Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2230 holding.
  • Virtu KCG Holdings first reported a position in Navidea Biopharmaceuticals Inc. in Q3 2013 and has held it in 12 quarters since.
  • 52 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.